QLG2198

· Qilu Pharmaceutical (Hainan) Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QLG2198, covering 2024-06-21 to 2024-06-21. Get the full timeline:

Most recent: Clinical Trial Update: Phase 3 Study of QLG2198 in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe Pruritus [Phase 3]